Literature DB >> 16842323

Comparison of staging systems to predict survival in hepatocellular carcinoma.

Sonia Pascual1, Pedro Zapater, José Such, Antonio García-Herola, Laura Sempere, Javier Irurzun, José María Palazón, Fernando Carnicer, Miguel Pérez-Mateo.   

Abstract

PURPOSE: Some new staging systems in hepatocellular carcinoma (HCC) have been described in the last years. The aim of this study was to compare the survival-predicting capacity of some variables and the prognostic classifications.
METHODS: Demographic, clinical, analytical variables and tumour characteristics were collected in a study including 115 patients with HCC. Predictors of survival were identified using the Kaplan-Meier test and the Cox model. Comparison between different staging systems was carried out.
RESULTS: The 1-, 2- and 3-year estimated survival was 65%, 45% and 30%, respectively. Child-Pugh score and alpha-fetoprotein level greater than 400 UI/l were independent predictors of survival in the Cox model. Although all systems correctly differentiated between patients regarding survival (Kaplan-Meier, log rank < 0.05 for all), the Barcelona Clinic Liver Cancer (BCLC) showed a better discriminatory ability than the other evaluated scores. In addition, the independent homogenizing ability and stratification value of BCLC was better than that of other systems. On the contrary, model for end-stage liver disease (MELD) showed the worst results.
CONCLUSIONS: Child-Pugh score and alpha-fetoprotein levels were the only independent predictors of survival in patients with HCC. Child-Pugh score showed a better prediction value for survival when compared with MELD. BCLC is more accurate than the other prognostic models evaluated in this investigation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16842323     DOI: 10.1111/j.1478-3231.2006.01282.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  12 in total

Review 1.  Staging systems of hepatocellular carcinoma: a review of literature.

Authors:  Marcello Maida; Emanuele Orlando; Calogero Cammà; Giuseppe Cabibbo
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 2.  Staging systems for hepatocellular carcinoma: Current status and future perspectives.

Authors:  Akiyoshi Kinoshita; Hiroshi Onoda; Nao Fushiya; Kazuhiko Koike; Hirokazu Nishino; Hisao Tajiri
Journal:  World J Hepatol       Date:  2015-03-27

3.  Major Liver Resection for Large and Locally Advanced Hepatocellular Carcinoma.

Authors:  Viniyendra Pamecha; Shridhar Vasantrao Sasturkar; Piyush Kumar Sinha; Shyam Sundar Mahansaria; Kishore G S Bharathy; Senthil Kumar; Archana Rastogi
Journal:  Indian J Surg       Date:  2016-09-03       Impact factor: 0.656

4.  Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study.

Authors:  Brian I Carr; Petr Pancoska; Robert A Branch
Journal:  Hepatol Int       Date:  2009-12-24       Impact factor: 6.047

Review 5.  Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols.

Authors:  Danijel Galun; Dragan Basaric; Marinko Zuvela; Predrag Bulajic; Aleksandar Bogdanovic; Nemanja Bidzic; Miroslav Milicevic
Journal:  World J Hepatol       Date:  2015-09-18

6.  A conceptual proposal for staging ductal cholangiocarcinoma.

Authors:  Boris R A Blechacz; William Sanchez; Gregory J Gores
Journal:  Curr Opin Gastroenterol       Date:  2009-05       Impact factor: 3.287

7.  Model for end-stage liver disease (MELD) score and cost-effectiveness on living donor liver transplantation.

Authors:  Takafumi Ichida; Yutaka Narita; Romi Murakami
Journal:  J Gastroenterol       Date:  2006-10       Impact factor: 6.772

8.  Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt.

Authors:  Asmaa Ibrahim Gomaa; Mohamed Saad Hashim; Imam Waked
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

Review 9.  Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies.

Authors:  Danijel Galun; Tatjana Srdic-Rajic; Aleksandar Bogdanovic; Zlatibor Loncar; Marinko Zuvela
Journal:  J Hepatocell Carcinoma       Date:  2017-07-11

Review 10.  Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies.

Authors:  Puneeta Tandon; Guadalupe Garcia-Tsao
Journal:  Liver Int       Date:  2008-12-24       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.